2016•Journal of HepatologyRequires access

PBI-4050 Decreases Hepatic Stellate Cell Activation and Ameliorates Fibrosis in Carbon Tetrachloride (CCL4)- Induced Hepatic Fibrosis Model

François Sarra‐Bournet, Brigitte Grouix, Kathy Hince, A. Felton, Mikaël Tremblay, Shaun Abbott, Jean‐Simon Duceppe, Boulos Zacharie, Pierre Laurin, Lyne Gagnon

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Carbon tetrachloride, Hepatic stellate cell, Hepatic fibrosis, CCL4, Fibrosis, Medicine, Liver fibrosis, Chemistry

Back to paper search Browse research topics Original source

PBI-4050 Decreases Hepatic Stellate Cell Activation and Ameliorates Fibrosis in Carbon Tetrachloride (CCL4)- Induced Hepatic Fibrosis Model — Research Paper | ScholarLens